Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Masashi Baba"'
Publikováno v:
International Workshop on Advanced Imaging Technology (IWAIT) 2023.
Autor:
Shintaro Takao, Seishi Kono, Masaru Miyashita, Muneharu Konishi, Ikuo Kokufu, Hirofumi Suwa, Koushiro Kitatsuji, Yutaka Konishi, Isao Sakita, Masayuki Nishino, K Yamagami, Hidefumi Nishikawa, Masahiro Kishimoto, Keisuke Miyauchi, Takashi Matsumoto, Toshitaka Okuno, Akihiro Miya, Koushi Oh, Masashi Baba, Kazuyuki Wakita, Toshiharu Hidaka, Takashi Hashimoto, Yoko Sakoda, Shigetoshi Ichii, Yasuo Miyoshi, Junya Minohata, Yuichiro Kikawa, Chiyomi Egawa
Publikováno v:
Cancer Research. 80:P5-12
Background Five-year adjuvant treatment with aromatase inhibitors is a standard treatment for postmenopausal women with estrogen receptor-positive breast cancer. However, aromatase inhibitor-related adverse events, including joint and vasomotor sympt
Autor:
Hidekazu Takahashi, Masahiro Hiratsuka, Masaru Murata, Masayuki Yamamoto, Masashi Baba, Nobuo Tanaka, Osamu Takayama
Publikováno v:
International Surgery. 104:439-445
The objectives of this study are to clarify the significance of persistent descending mesocolon (PDM), a kind of intestinal malrotation, in laparoscopic colorectal surgery and present potentially useful preoperative diagnostic methods for PDM. Althou
Autor:
Masahiro Kishimoto, Masaru Miyashita, Masayuki Nishino, Takashi Matsumoto, Yutaka Konishi, Shigetoshi Ichii, Toshiharu Hidaka, Masashi Baba, Takashi Hashimoto, Muneharu Konishi, Hidefumi Nishikawa, Yoko Sakoda, Ikuo Kokufu, Shintaro Takao, Akihiro Miya, Koushiro Kitatsuji, Isao Sakita, Junya Minohata, Kazuyuki Wakita, Koushi Oh, Kazuhiko Yamagami, Yuichiro Kikawa, Toshitaka Okuno, Seishi Kono, Keisuke Miyauchi, Kouhei Akazawa, Kaori Tane, Chiyomi Egawa, Hirofumi Suwa, Yasuo Miyoshi
Publikováno v:
Breast Cancer. 24:528-534
Adverse events related to endocrine therapies have a major impact not only on patients’ quality of life but also on treatment discontinuation. Although vasomotor symptoms induced by aromatase inhibitors are frequently recognized, risk factors, espe
Autor:
Ikuo Kokufu, Toshiharu Hidaka, Hirofumi Suwa, Seishi Kono, Masashi Baba, Koushiro Kitatsuji, Takashi Matsumoto, Yoko Sakoda, Isao Sakita, Hidefumi Nishikawa, Muneharu Konishi, Shigetoshi Ichii, Toshitaka Okuno, Akihiro Miya, Junya Minohata, Chiyomi Egawa, Koushi Oh, Kazuyuki Wakita, Yuichiro Kikawa, Masahiro Kishimoto, Yasuo Miyoshi, Keisuke Miyauchi, Kazuhiko Yamagami, Takashi Hashimoto, Yutaka Konishi, Masayuki Nishino, Shintaro Takao, Masaru Miyashita
Publikováno v:
Cancer Research. 75:P1-12
Background: Adjuvant five-year treatment with aromatase inhibitors is standard for postmenopausal women with estrogen receptor positive breast cancer. However, aromatase inhibitor-related adverse events including joint symptoms and vasomotor symptoms
Publikováno v:
Journal of Chemical Engineering of Japan. 48:862-871
Publikováno v:
KAGAKU KOGAKU RONBUNSHU. 41:397-405
Publikováno v:
SIGGRAPH Posters
When synthesizing CG images with real image as a background, it is necessary to estimate the lighting environment such as intensities and directions of light sources from real images. In previous study [Baba et al. 2016], except for the high intensit
Publikováno v:
JOURNAL OF CHEMICAL ENGINEERING OF JAPAN. 47:521-529
The aim of this study is to construct a simple heat-transfer model to present the temperature of the interface between the polymer electrolyte membrane (PEM) and the catalyst layer at the cathode, i.e., the reaction surface, in a single cell of polym
Autor:
Takashi Matsumoto, Minoru Yoshida, K. Hirokaga, Yutaka Konishi, Masayuki Nishino, Masashi Baba, Hirofumi Suwa, Junya Minohata, Keisuke Miyauchi, Muneharu Konishi, Chiyomi Egawa, Yuichiro Kikawa, Yasuo Miyoshi, K Yamagami, Toshitaka Okuno, Shigetoshi Ichii, Takashi Hashimoto, Shintaro Takao, Masaru Miyashita, Kazuyuki Wakita
Publikováno v:
Cancer Research. 73:P1-13
Background: Endocrine treatment-related adverse events have a strong impact on patients’ quality of life and sometimes result in treatment discontinuation. Since joint symptoms are the most frequently recognized side-effect of aromatase inhibitors,